← Back to home

UNRESECTABLE OR ADVANCED CLEAR CELL RENAL CELL CARCINOMA THAT HAS PROGRESSED AFTER PREVIOUS IMMUNOTHERAPY

Clinical trials for UNRESECTABLE OR ADVANCED CLEAR CELL RENAL CELL CARCINOMA THAT HAS PROGRESSED AFTER PREVIOUS IMMUNOTHERAPY explained in plain language.

Never miss a new study

Get alerted when new UNRESECTABLE OR ADVANCED CLEAR CELL RENAL CELL CARCINOMA THAT HAS PROGRESSED AFTER PREVIOUS IMMUNOTHERAPY trials appear

Sign up with your email to follow new studies for UNRESECTABLE OR ADVANCED CLEAR CELL RENAL CELL CARCINOMA THAT HAS PROGRESSED AFTER PREVIOUS IMMUNOTHERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for tough kidney cancer cases: testing a Double-Acting drug combo

Disease control Not yet recruiting

This study is testing a new two-drug combination for people with advanced kidney cancer that has spread or cannot be removed by surgery, and whose cancer has gotten worse after previous immunotherapy. The trial will see if adding a new drug called JS004 to an existing immunothera…

Matched conditions: UNRESECTABLE OR ADVANCED CLEAR CELL RENAL CELL CARCINOMA THAT HAS PROGRESSED AFTER PREVIOUS IMMUNOTHERAPY

Phase: PHASE2 • Sponsor: RenJi Hospital • Aim: Disease control

Last updated Mar 19, 2026 14:56 UTC

UNRESECTABLE OR ADVANCED CLEAR CELL RENAL CELL CARCINOMA THAT HAS PROGRESSED AFTER PREVIOUS IMMUNOTHERAPY

Get alerted when new UNRESECTABLE OR ADVANCED CLEAR CELL RENAL CELL CARCINOMA THAT HAS PROGRESSED AFTER PREVIOUS IMMUNOTHERAPY trials appear

New hope for tough kidney cancer cases: testing a Double-Acting drug combo